Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Brenetafusp is an experimental fusion protein being developed for cancer immunotherapy. Though specific details about its targets and mechanisms are limited fusion proteins such as Brenetafusp are engineered to engage multiple components of the immune system or tumor cells potentially improving anti-cancer responses. Clinical investigations are underway to determine its safety and therapeutic potential.
仅用于科研。不用于诊断过程。未经明确授权不得转售。